Supply Chain Fragility in Generic Insulin Markets
Sarah Jenkins · 5 min
Eli Lilly's Market Cap Surge: The Weight-Loss Drug Ripple Effect
The GLP-1 wave is reshaping capital allocation across the pharma landscape.
By Sarah Chen•6 min read•
A trillion-dollar question
Investors are grappling with what a mature GLP-1 market means for adjacent categories.
Winners and losers
Device makers exposed to obesity surgery are being asked hard questions.
Share
Related coverage
The mRNA Revolution Moves to Pancreatic Cancer Trials
Sarah Chen · 8 min
The Vanadium Brief
Every Monday morning, the definitive analysis of healthcare markets in your inbox.